Indeed, IL4i1 is associated with reduced immune responses toward malignancies (26, 45, 46, 133) and poor survival in several cancer types including melanoma, glioma, and ovarian cancer (26, 46, 134). This evidence concerns the gene IL4I1 and cancer.